[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Alpha Hunter posts on X about $uthr, $lqda, saving, logic the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXX%
Social topic influence $uthr #8, $lqda #9, saving 3.85%, logic XXXX%
Top accounts mentioned or mentioned by @bleeckerst @perryglasenberg @golfnut48846224 @paulall95402077 @hcbgreatwall @johndoeknowsguy @george_deng7
Top assets mentioned United Therapeutics, Corp. (UTHR)
Top posts by engagements in the last XX hours
"$LQDA - The idea that a judge would take away a life saving drug from people who need it which is what $UTHR wants is anathema to all logic and justice. It has also never happened - a life saving branded drug has never been pulled from the market due to patents. XXX is a pop patent - it is a nonsense patent to begin with. $UTHR has tried and failed at other patents that were far more real"
X Link @AlphaHunte79332 2025-09-22T15:32Z XXX followers, 6183 engagements
"In the '793 ruling Judge Andrews found that a DPI was obvious. During the trial the Judge said that he thought a DPI was obvious. The key patent claim that everyone is worried about here is claim XX which is about using whether a DPI is obvious. To believe that $UTHR is going to win this patent case you have to believe that the judge who has a written opinion and a clear view stated at trial goes against those views and favors $UTHR on this DPI being obvious matter. The reason why some of these legal analysts believe that that could happen is that $LQDA rested their invalidity argument with"
X Link @AlphaHunte79332 2025-09-25T19:55Z XXX followers, XXX engagements
"After the market close Judge Andrews asked for briefing from $LQDA and $UTHR about the recently decided case Bayer versus Mylan that came out yesterday. Here is Gemini's quick take on what this decision means for this '327 case. This is a significant development that provides powerful direct support for Liquidia's invalidity argument. The Federal Circuit's decision in Bayer Pharma v. Mylan gives Liquidia new and controlling legal precedent to argue that UTC's dependent claims (5 X X and 17) lack patentable weight and are therefore invalid along with claim X. This ruling is a major positive"
X Link @AlphaHunte79332 2025-09-25T00:33Z XXX followers, 37.8K engagements